arrow
Back
D

David W. Cescon

university health network

53H-index
403Paper Count
1.4WCitation Count
Published Papers 146
Publication Date
A chromatin-informed transcriptional regulatory framework to stratify patients and guide therapy selection in triple-negative breast cancer
err2026-08-06
err0
errOAAI
errShalini Bahl; Nergiz Dogan-Artun; Julia Nguyen; Hassan Mahmoud; Wail Ba-alawi; Seyed Ali Madani Tonekaboni; Komaldeep Kaur Kang; Meghan McGuire; Chantal Tobin; Jennifer Silvester; Paul Savage; Lucie Cressot; Ankita Nand; Guanqiao Feng; Paul Guilhamon; Arvind Singh Mer; Christopher Arlidge; Mitchell J. Elliott; Morag Park; David W. Cescon; Benjamin Haibe-Kains; Mathieu Lupien
errShare
errSave
Methylation-based ctDNA monitoring in metastatic breast cancer during CDK4/6 inhibitor therapy
err2026-06-04
err0
errOAAI
errMitchell J. Elliott; Jesús Fuentes-Antrás; Sasha C. Main; Aaron Dou; Elizabeth Shah; Caroline Weipert; Geethika Yalamanchili; Taylor Bird; June Roh; Celeste Yu; Michelle B. Nadler; Eitan Amir; Hal K. Berman; Lillian L. Siu; Philippe L. Bedard; David W. Cescon
errShare
errSave
Pan-Cancer Pre-Treatment ctDNA Detection Using a Highly Sensitive Tumor-Informed Assay
err2026-04-30
err0
errOAAI
errScott Strum; Clodagh Murray; Sofia Genta; Enrique Sanz-Garcia; Albiruni Razak; Stephanie Lheureux; Christodoulos Pipinikas; Ben X. Wang; Amber Chevalier; Christopher G. Smith; Anna Spreafico; Lillian L. Siu; Mitchell Elliott; David W. Cescon
errShare
errSave
Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with Triple Negative Breast Cancer in Both the Early and Metastatic Setting 2025
err2026-04-27
err0
errOAAI
errChristine Simmons; Omar F. Khan; Christine Brezden-Masley; David W. Cescon; Anil Abraham Joy; Nathalie LeVasseur; Katarzyna J. Jerzak; Karen A. Gelmon; Sandeep Sehdev; Stephen Chia; Marc Webster; Scott Edwards; Aalok Kumar; Jeffrey Q. Cao; Jean-François Boileau; Kara Laing; Nathaniel Bouganim; Mita Manna; on behalf of Patient Advocacy, Breast Cancer Canada
errShare
errSave
Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HR+/HER2− Metastatic Breast Cancer 2025
err2026-02-15
err0
errOAAI
errKatarzyna J. Jerzak; Aalok Kumar; Jean-François Boileau; Nathaniel Bouganim; Christine Brezden-Masley; Jeffrey Q. Cao; David W. Cescon; Stephen Chia; Scott Edwards; Anil Abraham Joy; Kara Laing; Nathalie LeVasseur; Sasha Lupichuk; Sandeep Sehdev; Christine Simmons; Marc Webster; Karen A. Gelmon; Mita Manna; on behalf of patient advocacy, Breast Cancer Canada
errShare
errSave
Binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations: results from the Phase II BEAVER trial
err2026-01-03
err0
errOAAI
errApril A. N. Rose; Jennifer Maxwell; Emmanuelle Rousselle; Chantel L. Mukonoweshuro; Islam E. Elkholi; Melody Riaud; Marco Biondini; Erica Cianfarano; Isabel Soria-Bretones; Chantal Tobin; Meghan McGuire; Rhoda W. Y. Law; Andrew J. Elia; Ben X. Wang; Ian King; Tong Zhang; Trevor J. Pugh; Zaid Saeed Kamil; Marcus Butler; Frances A. Shepherd; Natasha B. Leighl; Albiruni Abdul Razak; Aaron Hansen; Samuel D. Saibil; Philippe L. Bedard; Peter M. Siegel; Lillian L. Siu; David W. Cescon; Anna Spreafico
errShare
errSave
The role of circulating tumor cell-associated genes in the progression of estrogen receptor-positive breast cancer
err2025-12-15
err0
errOAAI
errMartin Rotbauer; Melanie Dawe; Kevin C. J. Nixon; Julissa Tsao; Tanja Durbic; Monika Sharma; Sheng-Ben Liang; Jie Zhang; Nakita E. K. Gopal; Miralem Mrkonjic; Najd Alshamlan; Adnan Karavelic; Ciara Murray; David W. Cescon; Philippe L. Bedard; Susan J. Done
errShare
errSave
Simulating cell-free chromatin using preclinical cancer models for liquid biopsy applications
err2025-11-22
err0
errOAAI
errSasha C. Main; Steven D. De Michino; Lucas Penny; Aleem Aamir; Tina Keshavarzian; Benjamin H. Lok; Robert Kridel; David W. Cescon; Michael M. Hoffman; Mathieu Lupien; Scott V. Bratman
errShare
errSave
Artemis (DCLRE1C) Acts as a Target to Enhance Radiotherapy Response in Triple-Negative Breast Cancer
err2025-10-10
err0
errOAAI
errVasudeva Bhat; Kelsie L. Thu; Anayra de Fatima Goncalves Santiago; Anna C. Bonvissuto; Farhad Ghasemi; David Goodale; Michael V. Roes; Daniel T. Passos; Frederick A. Dick; David W. Cescon; Alison L. Allan; Armen Parsyan
errShare
errSave
Machine learning-assisted exploration of multidrug-drug administration regimens for organoid arrays
err2025-07-30
err0
PREAI
errIlya Yakavets; Sina Kheiri; Jennifer Cruickshank; Riley J. Hickman; Faeze Rakhshani; Matteo Aldeghi; Ella M. Rajaonson; Edmond W.K. Young; Alán Aspuru-Guzik; David W. Cescon; Eugenia Kumacheva
errShare
errSave
Personalized ctDNA monitoring in metastatic HR+/HER2− breast cancer patients during endocrine and CDK4/6 inhibitor therapy
err2025-07-19
err0
errOAAI
errJesús Fuentes-Antrás; Mitchell J. Elliott; Sasha C. Main; Philippe Echelard; Aaron Dou; Philippe L. Bedard; Eitan Amir; Michelle B. Nadler; Nicholas Meti; Nancy Gregorio; Elizabeth Shah; Emily Van de Laar; Celeste Yu; Yangqing Deng; Lisa Gates; Clodagh Murray; Christopher G. Smith; Amber Chevalier; Scott V. Bratman; Lillian L. Siu; Hal K. Berman; David W. Cescon
errShare
errSave
Comprehensive tumor-agnostic evaluation of genomic and epigenomic-based approaches for the identification of circulating tumor DNA in early-stage breast cancer
err2025-06-01
err0
errOAAI
errM.J. Elliott; J. Kim; A. Dou; J. Fuentes Antrás; E. Amir; M.B. Nadler; E. Van de Laar; C. Yu; R. Cheikh; A. Silvestro; L.L. Siu; P.L. Bedard; H.K. Berman; D.W. Cescon
errShare
errSave
Identification of targetable vulnerabilities of PLK1-overexpressing cancers by synthetic dosage lethality
err2025-05-09
err0
errOAAI
errChelsea E. Cunningham; Frederick S. Vizeacoumar; Yue Zhang; Liliia Kyrylenko; Simon Both; Vincent Maranda; He Dong; Jared D.W. Price; Peng Gao; Konrad Wagner; Yingwen Wu; Mary Lazell-Wright; Ashtalakshmi Ganapathysamy; Rithik Hari; Kalpana K. Bhanumathy; Connor Denomy; Anjali Saxena; Jeff P. Vizeacoumar; Alain Morejon Morales; Faizaan Khan; Shayla Mosley; Angie Chen; Tetiana Katrii; Ben G.E. Zoller; Karthic Rajamanickam; Prachi Walke; Lihui Gong; Hardikkumar Patel; Hussain Elhasasna; Renuka Dahiya; Omar Abuhussein; Anton Dmitriev; Tanya Freywald; Erika Prando Munhoz; Eytan Ruppin; Joo Sang Lee; Katharina Rox; Martin Koebel; Laura Hopkins; Cheng Han Lee; Sunil Yadav; Gilles Gasparoni; Jörn Walter; Anand Krishnan; Raju Datla; Behzad Toosi; Kristi Baker; Jalna Meens; David W. Cescon; Laurie Ailles; Scot C. Leary; Yuliang Wu; Martin Empting; Alexandra K. Kiemer; Andrew Freywald; Franco J. Vizeacoumar
errShare
errSave
TROPION-Breast05: a randomized phase III study of Dato-DXd with or without durvalumab versus chemotherapy plus pembrolizumab in patients with PD-L1-high locally recurrent inoperable or metastatic triple-negative breast cancer
err2025-04-17
err0
errOAAI
errPeter Schmid; Mafalda Oliveira; Joyce O’Shaughnessy; Massimo Cristofanilli; Stephanie L. Graff; Seock-Ah Im; Sherene Loi; Shigehira Saji; Shusen Wang; David W. Cescon; Tina Hovey; Agata Nawrot; Karson Tse; Petra Vukovic; Giuseppe Curigliano
errShare
errSave
Longitudinal evaluation of circulating tumor DNA in patients undergoing neoadjuvant therapy for early breast cancer using a tumor-informed assay
err2025-02-21
err0
errOAAI
errElliott, Mitchell J.; Echelard, Philippe; Pipinikas, Christodoulos; Main, Sasha; Antras, Jesus Fuentes; Dou, Aaron; Veitch, Zachary; Amir, Eitan; Nadler, Michelle B.; Meti, Nicholas; Atenafu, Eshetu; Shah, Elizabeth; Yu, Celeste; Campbell, Nathan; Ventura, Robert; Siu, Lillian L.; Bedard, Philippe L.; Berman, Hal K.; Cescon, David W.
errShare
errSave
IND.241: A Canadian Cancer Trials Group liquid-biopsy informed platform trial to evaluate treatment in CDK4/6-inhibitor resistant ER +/HER2-metastatic breast cancer
err2024-10-01
err0
PREAI
errCosci, C.; Jamme, P.; Kumar, V.; Nadler, M. B.; Rayson, D.; Melvin, J.; Rushton, M.; Awan, A.; Levasseur, N.; Chia, S.; Bedard, P.; Hilton, J.; Finn, S.; Tu, W.; Antras, J. F.; Unger, T. J.; Cescon, D.; Seymour, L.; Pearce, L.
errShare
errSave
Microfluidic Platform for Generating and Releasing Patient-Derived Cancer Organoids with Diverse Shapes: Insight into Shape-Dependent Tumor Growth
err2024-09-14
err0
errOAAI
errKheiri, Sina; Yakavets, Ilya; Cruickshank, Jennifer; Ahmadi, Fatemeh; Berman, Hal K.; Cescon, David W.; Young, Edmond W. K.; Kumacheva, Eugenia
errShare
errSave
Results from the randomized KEYNOTE-355 study of pembrolizumab plus chemotherapy for Asian patients with advanced TNBC
err2024-09-12
err0
errOAAI
errIm, Seock-Ah; Cortes, Javier; Cescon, David W.; Yusof, Mastura Md; Iwata, Hiroji; Masuda, Norikazu; Takano, Toshimi; Huang, Chiun-Sheng; Chung, Chi-Feng; Tsugawa, Koichiro; Park, Yeon Hee; Matsumoto, Koji; Inoue, Kenichi; Kwong, Ava; Loi, Sherene; Fu, Wei; Pan, Wilbur; Karantza, Vassiliki; Rugo, Hope S.; Schmid, Peter
errShare
errSave
Phase Ib expansion study of CX-5461 in patients with solid tumours and BRCA2 and/or PALB2 mutation
err2024-09-01
err0
PREAI
errPina, P. D. Soberanis; Lheureux, S.; Han, H.; Shapiro, G.; Provencher, D. M.; Rosen, L. S.; Sardesai, S.; Taylor, S.; Cescon, D.; Alqaisi, H. A.; Aparicio, S.; Sabantini, P.; Chao, T-I.; Huang, C-E.; Chen, M-C.; Mahmud, L.; Ye, X. Y.; Bowering, V.; Oza, A. M.
errShare
errSave